13th Annual Biomarkers Congress

Join us at the 13th Annual Biomarkers Congress, 15-16th Feb 2018, Manchester UK
Join us at the 13th Annual Biomarkers Congress, 15-16th Feb 2018, Manchester UK 22/08/2017 11:13

Europe’s most established Biomarkers Congress will attract 300+ delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions. This event will showcase over 55 presentations, case studies, novel technologies, round-table and panel discussions.

 

Across the two days, 6 interactive streams will focus on:

  • Biomarkers      in Drug Discovery & Development Therapeutic Areas: Autoimmune,      Immuno-oncology, Neuroscience, Oncology
  • Precision      Medicine, Companion Diagnostics, Molecular Diagnostics Development
  • Biomarkers      in Drug Discovery & Development Therapeutic Areas: Cardiovascular,      Rheumatology, Respiratory, COPD, Rare Diseases, Infectious Diseases,      Inherited Diseases
  • Innovations      in Biomarkers Research, Assay Development, Imaging, Data Integration      Methods, Bioinformatics, Trial Design
  • Biomarker:      Clinical Development & Clinical Trials
  • Innovative      Biology- NGS & Genomic Markers, Clinical Testing and Diagnostics      Development

Co-located with the 5th Annual Biomarker in Clinical Development Congress, this event provides a great opportunity for attendees to learn more about the latest status updates about the ever-changing regulatory landscape in clinical development, genomic approaches in drug development, RNAseq NGS in biomarker benchmarking and the advances made in NGS techniques in liquid biopsy.

Contact Danielle Dalby on d.dalby@oxfordglobal.co.uk for further information.

www.biomarkers-congress.com

Spotlight title

Antibodies intended for therapeutic clinical use must undergo screening in human tissue as part of any regulatory preclinical safety assessment.

Find out more

Tonsils; CD8_Foxp3 Dual Stain, Co-localisation analysis

Find out more